OrthoAxis - Product

Product Overview

The SCYLLA™ cellular bone matrices are viable allogeneic bone allografts containing viable bone-derived cells. Each SCYLLA™ product contains the three key components that are ideal for bone formation:

-An osteoconductive three-dimensional scaffold with cortical and cancellous components

-A demineralized bone scaffold with osteoinductive potential, which provides exposure of signaling molecules and bone morphogenetic proteins1

-Bone-derived cells to support osteogenic healing processes

Key Features of SCYLLA™ Product Line

-Three (3) unique scaffold blends for optimal handling
characteristics: SCYLLA™, SCYLLA™ Moldable,
SCYLLA™-F Moldable.

-Proprietary, optimized bone microparticulate size
range of 100-300 μm.

-Novel DMSO-free cryoprotectant, with no rinsing and
decanting steps required prior to use.

-Average cell viability of the cell component exceeds
80% post-thaw.

-Minimum of 150,000 viable cells per cc of allograft
post-thaw.

-Convenient handling and preparation in the OR, with
total preparation time on the back table of less than
20 minutes.

-Four (4) hour working window for implantation after
thaw without loss of cell viability.

-Product shelf-life is two (2) years from date of
processing when stored at -65°C or colder.

https://www.cambermedtech.com/scylla-cellular-bone-matrix

Camber Spine Website

Technique Tips

Reviews

X-Rays

Visitors Also Viewed

Scylla Cellular Bone Matrix

(0 Reviews)
(0 Comments)